Document Detail

Oral contraceptives in polycystic ovary syndrome.
MedLine Citation:
PMID:  25003228     Owner:  NLM     Status:  Publisher    
Polycystic ovary syndrome (PCOS) is the most common endocrine disorder of women of reproductive age and combined oral contraceptives (OCs) are often the first---line treatment of the syndrome by improving hyperandrogenism and regulating menstrual cycles. Oral contraceptives have some cardiovascular and metabolic effects that varies among different formulations depending upon the dose and type of the both estrogen and progestin components. These cardiometabolic effects of OCs raise some concerns about their long---term use in PCOS, but available data suggest that the benefits outweigh the risks. More studies are needed to clarify the safety of long---term use of OCs in PCOS.
N Helvaci; B O Yildiz
Related Documents :
25274238 - Late hematological improvement of myelodysplastic syndrome following treatment with 5-a...
22431278 - Abdominal aortic calcification in young adult survivors of childhood acute lymphoblasti...
25368838 - Nonsurgical treatment of stylohyoid (eagle) syndrome: a case report.
25386238 - Cutaneous papules in a patient with acquired immunodeficiency syndrome.
14570238 - King-kopetzky syndrome in the light of an ecological conceptual framework.
21071978 - Genetics of familial renal cancers.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2014-7-08
Journal Detail:
Title:  Minerva endocrinologica     Volume:  -     ISSN:  0391-1977     ISO Abbreviation:  Minerva Endocrinol.     Publication Date:  2014 Jul 
Date Detail:
Created Date:  2014-7-8     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8406505     Medline TA:  Minerva Endocrinol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Endometriosis: translation of molecular insights to management.
Next Document:  Engraftment and lineage potential of adult hematopoietic stem and progenitor cells is compromised fo...